Karin has three decades of international experience having previously held leadership positions in the US at Millennium Pharmaceuticals and Exelixis and in the UK at Thermo Fisher Scientific, Horizon Discovery Group, PredictImmune, and Mogrify.
During this time Karin has brought over 20 innovative products to market internationally, including in vitro diagnostics (IVD) tests and led several large observational studies/clinical trials (> 20 centres each) in both US, UK and China. Her deep scientific knowledge is complemented by significant experience in regulatory, legal and commercial. Throughout her career, Karin has demonstrated her talent in scaling teams, including R&D and manufacturing, in a regulated environment. She also established several successful pilot projects with pharma/biotech as early proof-of-concepts.
Karin obtained her PhD in Molecular Biology from the University of Southern California in Los Angeles sponsored by one of the most prestigious scholarships offered to German citizens, followed by two years of post-doctoral research in genetics at the University of Cambridge as a EMBO fellow supporting outstanding future talent